Emphysema NewsNews on Emphysema continually updated from thousands of sources around the net.FDA Advises Patients to Switch to HFA-Propelled Albuterol Inhalers...- May 30, 2008 The U.S. Food and Drug Administration today issued a public health advisory to alert patients, caregivers and health care professionals to switch to hydrofluoroalkane -propelled albuterol inhalers because ...http://www.topix.net/health/emphysema/2008/05/fda-advises-patients-to-switch-to-hfa-propel... Chattanooga: Asthma patients to pay more to inhale- May 26, 2008 Hixson resident Vesta Hudson has used a generic inhaler for 18 years to relieve acute asthma attacks.http://www.topix.net/health/emphysema/2008/05/chattanooga-asthma-patients-to-pay-more-to-i... Study: Significantly Improved Bronchodilation & Symptom Control with Combo Therapy- May 24, 2008 A newly published study presents data demonstrating that patients with Chronic Obstructive Pulmonary Disease , including emphysema and chronic bronchitis, experienced markedly improved bronchodilation and ...http://www.topix.net/health/emphysema/2008/05/study-significantly-improved-bronchodilation... COPD: Concomitant Treatment With Nebulized Formoterol Fumarate & Tio - Significant Improvements- May 22, 2008 Main Category: Respiratory Asthma Also Included In: Clinical Trials Drug Trials Article Date: 21 May 2008 A newly published study presents data demonstrating that patients with Chronic Obstructive Pulmonary ...http://www.topix.net/health/emphysema/2008/05/copd-concomitant-treatment-with-nebulized-fo... Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic & Pharmacodynamic Profile to DPI- May 21, 2008 Data presented today at the International Conference of the American Thoracic Society demonstrate that Perforomist Inhalation Solution has a pharmacodynamic and pharmacokinetic profile that is comparable to the ...http://www.topix.net/health/emphysema/2008/05/nebulized-formoterol-fumarate-has-comparable... Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium...- May 20, 2008 "These data provide physicians with a new and valuable treatment option for COPD patients with moderate to severe manifestations of the disease." Perforomist Inhalation Solution was approved in 2007 by the FDA for long-term, twice-daily maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease , including chronic ... via Rehab Managementhttp://www.topix.net/health/emphysema/2008/05/concomitant-use-of-nebulized-formoterol-fuma... Olympus Medical Systems Corp. and Spiration, Inc. Sign Agreement to...- May 19, 2008 REDMOND, Wash. & TOKYO - Olympus Medical Systems Corp. and Spiration, Inc. announced today that the companies have signed a definitive agreement granting Olympus exclusive marketing and distribution rights in ... via Earth Timeshttp://www.topix.net/health/emphysema/2008/05/olympus-medical-systems-corp-and-spiration-i... Drug companies chasing profits, cheating patients- May 13, 2008 "The core issue is profits, not patients" 'High-price Doxofylline being promoted as an alternative to low-price theophylline' Doxofylline bulk drug is not a patented medicine and can be purchased in tons in China NEW DELHI: Exploiting the ignorance of ... via The Hinduhttp://www.topix.net/health/emphysema/2008/05/drug-companies-chasing-profits-cheating-pati... |